VON WILLEBRAND DISEASE (VWD), TYPE 2
Clinical trials for VON WILLEBRAND DISEASE (VWD), TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new VON WILLEBRAND DISEASE (VWD), TYPE 2 trials appear
Sign up with your email to follow new studies for VON WILLEBRAND DISEASE (VWD), TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for bleeding disorder: experimental drug HMB-002 enters human trials
Disease control Recruiting nowThis study tests a new medicine, HMB-002, for people with Von Willebrand disease (types 1 and 2), a bleeding disorder. The trial has two parts: first, a single dose to check safety and how the drug works in the body; second, repeated doses to see if it helps control bleeding. Abo…
Matched conditions: VON WILLEBRAND DISEASE (VWD), TYPE 2
Phase: PHASE1, PHASE2 • Sponsor: Hemab ApS • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New drug aims to stop bleeding in rare blood disorder
Disease control Recruiting nowThis study tests a new drug called BT200 in 4-6 adults with type 2B von Willebrand disease who have low platelets and a history of bleeding. The drug is designed to slow the breakdown of a key clotting protein, which may raise platelet levels and reduce bleeding. Participants wil…
Matched conditions: VON WILLEBRAND DISEASE (VWD), TYPE 2
Phase: PHASE2 • Sponsor: Medical University of Vienna • Aim: Disease control
Last updated May 12, 2026 13:41 UTC